Merck KGaA Buys Bio-Techne for $11.3B; TECH Pops 20%
Merck KGaA acquires Bio-Techne for $11.3B in cash at $73/share, a 24% premium. TECH jumped 20% to $70.70 and the arb spread of 3.2% signals a tight deal.
Merck KGaA acquires Bio-Techne for $11.3B in cash at $73/share, a 24% premium. TECH jumped 20% to $70.70 and the arb spread of 3.2% signals a tight deal.
T-Bills, T-Notes, and T-Bonds explained: maturities, coupon math, auction schedule, and the live June 2026 yield curve, with worked examples.
SpaceX sold $25B across five tranches in its first-ever bond sale, drawing nearly $89B in orders and tightening spreads 25 bps from talk.
SanDisk surged 21% intraday after Micron’s record Q3 print, then gave back gains as profit-takers crowded the AI memory trade.
P/E ratio formula, trailing vs forward, sector benchmarks, Shiller CAPE, and the five cases where price-to-earnings flat-out misleads investors.
Headline PCE jumped to 4.1% YoY in May, core to 3.4%. September rate-hike odds surged to ~68% from 29% a week ago as Treasury yields wobbled.
Apple fell 5% after raising Mac and iPad prices on memory costs. Micron jumped 14% to $1,195 on Q3 FY26 beat — same AI memory squeeze, both sides.
How a company goes public, step by step: the S-1 filing, bookbuilding, share allocation under FINRA Rule 5130, and the greenshoe that stabilizes the first weeks of trading.
Six months after the Fed ended balance sheet runoff, its portfolio shows a clean pivot: Treasury holdings up $275B YoY, agency MBS down $191B.
OpenAI’s first custom inference chip Jalapeño, co-designed with Broadcom, lifted AVGO 3.4% June 24 and revives the hyperscaler ASIC challenge to Nvidia.